|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 83.28 USD | -0.20% |
|
+7.02% | +23.74% |
| Market Cap | 9.88B 8.68B 8.1B 7.44B 13.92B 946B 14.26B 96.07B 37.57B 468B 37.09B 36.28B 1,619B | P/E 2026 * |
12.5x | P/E 2027 * | 9.59x |
|---|---|---|---|---|---|
| Enterprise Value | 11.2B 9.84B 9.19B 8.43B 15.78B 1,073B 16.17B 109B 42.6B 531B 42.05B 41.14B 1,835B | EV / Sales 2026 * |
6.34x | EV / Sales 2027 * | 5.03x |
| Free-Float |
98.94% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Halozyme Therapeutics, Inc.
| 1 day | -0.20% | ||
| 1 week | +7.02% | ||
| Current month | +6.40% | ||
| 1 month | +7.90% | ||
| 3 months | +32.06% | ||
| 6 months | +13.55% | ||
| Current year | +23.74% |
| 1 week | 80.93 |  | 84.44 |
| 1 month | 73.89 | | 84.44 |
| Current year | 61.32 | | 84.44 |
| 1 year | 58.53 | | 84.44 |
| 3 years | 32.83 | | 84.44 |
| 5 years | 29.85 | | 84.44 |
| 10 years | 8.18 | | 84.44 |
| Manager | Title | Age | Since |
|---|---|---|---|
Helen Torley
CEO | Chief Executive Officer | 63 | 2014-01-05 |
David Ramsay
DFI | Director of Finance/CFO | 61 | 2013-04-30 |
| Director of Finance/CFO | - | 2026-06-07 |
| Director | Title | Age | Since |
|---|---|---|---|
Matthew Posard
BRD | Director/Board Member | 59 | 2013-03-27 |
Helen Torley
BRD | Director/Board Member | 63 | 2014-01-05 |
| Chairman | 61 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/8/26 | Fiscal year | Chief Executive Officer | 5,769 | 0.0049% | ||
| 7/1/26 | Free | Executive/Senior Manager | 56,055 | 0.0473% | ||
| 7/1/26 | Free | Chief Financial Officer | 168,986 | 0.1425% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.20% | +7.02% | +41.03% | +90.75% | 9.88B | |
| -1.11% | +2.27% | +57.76% | +22.59% | 322B | |
| -0.55% | +3.59% | +29.60% | -9.73% | 71.8B | |
| -1.96% | +2.16% | +3.29% | -2.43% | 8.64B | |
| -4.91% | -1.56% | -25.07% | -7.47% | 4.08B | |
| -0.57% | +0.14% | -41.61% | +6.52% | 3.61B | |
| -0.19% | -4.43% | -10.74% | +1.66% | 3.61B | |
| -2.43% | -0.79% | +39.22% | +53.09% | 2.7B | |
| +6.83% | +4.92% | -7.19% | -4.68% | 2.24B | |
| +0.85% | -7.87% | -28.56% | +19.69% | 1.79B | |
| Average | -0.42% | +0.43% | +5.77% | +17.00% | 43.03B | |
| Weighted average by Cap. | -1.00% | +4.38% | +48.58% | +17.70% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.77B 1.55B 1.45B 1.33B 2.49B 169B 2.55B 17.19B 6.72B 83.78B 6.64B 6.49B 290B | 2B 1.76B 1.64B 1.51B 2.82B 192B 2.89B 19.5B 7.62B 95.01B 7.53B 7.36B 328B |
| Net income | 812M 714M 666M 611M 1.14B 77.78B 1.17B 7.9B 3.09B 38.49B 3.05B 2.98B 133B | 1.03B 909M 848M 778M 1.46B 99.06B 1.49B 10.06B 3.93B 49.02B 3.88B 3.8B 169B |
| Net Debt | 1.32B 1.16B 1.08B 995M 1.86B 127B 1.91B 12.86B 5.03B 62.68B 4.96B 4.86B 217B | 205M 180M 168M 154M 289M 19.62B 296M 1.99B 779M 9.71B 769M 752M 33.57B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-29 | US$83.28 | -0.20% | 1,634,260 |
| 26-07-28 | US$83.45 | +2.41% | 2,623,608 |
| 26-07-27 | US$81.48 | -0.55% | 1,435,892 |
| 26-07-24 | US$81.93 | +1.35% | 1,661,209 |
| 26-07-23 | US$80.84 | +3.88% | 1,751,413 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HALO Stock
Select your edition
All financial news and data tailored to specific country editions
